GenMark Diagnostics Reports Q3 Financial Results

Published: Nov 04, 2016

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the third quarter ended September 30, 2016.

Revenue for the third quarter of 2016 was $10.8 million, an increase of 28% over the prior year period.

Back to news